AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25005193 — intervention group
Group type: COMPARATOR
Intervention: Comparison at 1 month after surgery
Number of subjects: 40
Study 25005193 — intervention group
Group type: COMPARATOR
Intervention: Comparison at 1 week after surgery
Number of subjects: 40
Study 25005193 — intervention group
Group type: COMPARATOR
Intervention: Comparison at 3 months after surgery
Number of subjects: 40
Study 22031621 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS‐690514, 200 mg after a high‐fat meal (951 kcal, 52% fat)
Number of subjects: 43
Study 22031621 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS‐690514, 200 mg after a light meal (336 kcal, 75% carbohydrate)
Number of subjects: 43
Study 22031621 — intervention group
Group type: COMPARATOR
Intervention: BMS‐690514, 200 mg while fasting
Number of subjects: 43
Study 20533105 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive sucralfate therapy plus conventional therapy
Number of subjects: 15
Study 20533105 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy alone
Number of subjects: 15
Study 18466925 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (15 mg/day)
Number of subjects: 18
Study 18466925 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (Estrogen 0.625 mg/d plus buspirone)
Number of subjects: 18
Study 18466925 — intervention group
Group type: COMPARATOR
Intervention: Control group (Buspirone only)
Number of subjects: 18
Study 15972174 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolene Hernia System (PHS)
Number of subjects: 50
Study 15972174 — intervention group
Group type: COMPARATOR
Intervention: Mayo repair
Number of subjects: 50
Study 15972174 — intervention group
Group type: COMPARATOR
Intervention: Onlay repair with mesh
Number of subjects: 50
Study 12142810 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral midazolam (0.5 mg/kg, maximum dose of 20 mg) with IV meperidine (2 mg/kg, maximum dose of 100 mg)
Number of subjects: 154
Study 12142810 — intervention group
Group type: COMPARATOR
Intervention: Oral diazepam (0.3 mg/kg, maximum dose of 10 mg) with IV meperidine (2 mg/kg, maximum dose of 100 mg)
Number of subjects: 154
Study 9927110 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin alfa (weekly doses subcutaneously on Days -21, -14, -7, and day of surgery)
Number of subjects: 490
Study 9927110 — intervention group
Group type: COMPARATOR
Intervention: Preoperative autologous blood donation (PAD)
Number of subjects: 490
Study 8667039 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefodizime 1 g i.m. qD (Group A)
Number of subjects: 238
Study 8667039 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefodizime 1 g i.m. BID (Group B)
Number of subjects: 238
Study 8667039 — intervention group
Group type: COMPARATOR
Intervention: Ceftriaxone 1 g i.m. qD (Group C)
Number of subjects: 238
Study 2201431 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin (70 mg/m2 intravenously)
Number of subjects: 298
Study 2201431 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin (70 mg/m2 intravenously) and Vindesine (3 mg/m2 intravenously)
Number of subjects: 298
Study 621282 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambient room temperature and water content
Number of subjects: 8
Study 621282 — intervention group
Group type: EXPERIMENTAL
Intervention: Body temperature and ambient water content
Number of subjects: 8
Study 621282 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambient room temperature fully saturated
Number of subjects: 8
Study 621282 — intervention group
Group type: EXPERIMENTAL
Intervention: Body temperature fully saturated air
Number of subjects: 8
Study 30926686 — intervention group
Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 128
Study 30926686 — intervention group
Group type: COMPARATOR
Intervention: Conscious Sedation (CS)
Number of subjects: 128
Study 30926686 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct aspiration technique
Number of subjects: 128
Study 30926686 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent retriever
Number of subjects: 128
Study 30926686 — intervention group
Group type: EXPERIMENTAL
Intervention: GA
Number of subjects: 128
Study 30926686 — intervention group
Group type: COMPARATOR
Intervention: CS
Number of subjects: 128
Study 28002882 — intervention group
Group type: EXPERIMENTAL
Intervention: LC28-0126 (0.3, 1, 3, 10, 25, 50, 100, or 200 mg)
Number of subjects: 89
Study 28002882 — intervention group
Group type: EXPERIMENTAL
Intervention: LC28-0126 (0.3 to 200 mg)
Number of subjects: 89
Study 26032952 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose (1.5 mg NES/0.5 mg E2)
Number of subjects: 18
Study 26032952 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium dose (3.0 mg NES/1.0 mg E2)
Number of subjects: 18
Study 26032952 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose (4.5 mg NES/1.5 mg E2)
Number of subjects: 18
Study 23602417 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM)
Number of subjects: 41
Study 23602417 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) with standard rehabilitation
Number of subjects: 41
Study 23602417 — intervention group
Group type: COMPARATOR
Intervention: Standard inpatient rehabilitation program
Number of subjects: 41
Study 21723049 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness training (MT)
Number of subjects: 88
Study 21723049 — intervention group
Group type: COMPARATOR
Intervention: American Lung Association's freedom from smoking (FFS)
Number of subjects: 88
Study 19187623 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 1973
Study 19187623 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 1973
Study 16719728 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 NRT ads
Number of subjects: 492
Study 16719728 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 Zyban ads
Number of subjects: 492
Study 16719728 — intervention group
Group type: COMPARATOR
Intervention: 4 ads promoting nonpharmacologic cessation services (quitline ads)
Number of subjects: 492
Study 15146339 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined pharmaco- and psychotherapy (COMBI)
Number of subjects: 0
Study 15146339 — intervention group
Group type: COMPARATOR
Intervention: Medication alone
Number of subjects: 0
Study 15146339 — intervention group
Group type: COMPARATOR
Intervention: Interpersonal psychotherapy
Number of subjects: 0
Study 11368131 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone 600 mg followed by misoprostol 400 microg 6-8 hours later (Group 1)
Number of subjects: 86
Study 11368131 — intervention group
Group type: COMPARATOR
Intervention: Mifepristone 600 mg followed by misoprostol 400 microg 48 hours later (Group 2)
Number of subjects: 86
Study 11368131 — intervention group
Group type: COMPARATOR
Intervention: Standard regimen (Group 2)
Number of subjects: 86
Study 11203554 — intervention group
Group type: EXPERIMENTAL
Intervention: Barrier membrane placement (e-PTFE)
Number of subjects: 12
Study 11203554 — intervention group
Group type: COMPARATOR
Intervention: No barrier membrane placement
Number of subjects: 12
Study 8678348 — intervention group
Group type: EXPERIMENTAL
Intervention: E-speed film
Number of subjects: 20
Study 8678348 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-enhanced RVG-S
Number of subjects: 20
Study 8678348 — intervention group
Group type: EXPERIMENTAL
Intervention: RVG-S with steep gradient enhancement (X-function)
Number of subjects: 20
Study 8678348 — intervention group
Group type: COMPARATOR
Intervention: Niobium filtration
Number of subjects: 20
Study 8678348 — intervention group
Group type: COMPARATOR
Intervention: CCD-based devices
Number of subjects: 20
Study 8678348 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast enhancement of digital images (RVG-S X-function)
Number of subjects: 20
Study 1360776 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.88 mg/kg oxatomide
Number of subjects: 9
Study 1360776 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg oxatomide
Number of subjects: 9
Study 6400576 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 1% prednisolone acetate
Number of subjects: 39
Study 6400576 — intervention group
Group type: EXPERIMENTAL
Intervention: Subconjunctival methylprednisolone sodium succinate
Number of subjects: 39
Study 6400576 — intervention group
Group type: COMPARATOR
Intervention: Untreated group (control)
Number of subjects: 39
Study 6400576 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid treated group (intervention)
Number of subjects: 39
Study 29768328 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate-midazolam
Number of subjects: 0
Study 29768328 — intervention group
Group type: COMPARATOR
Intervention: Propofol-midazolam
Number of subjects: 0
Study 27192347 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk calculator data
Number of subjects: 779
Study 27192347 — intervention group
Group type: COMPARATOR
Intervention: Control group (clinical vignettes alone)
Number of subjects: 779
Study 25060015 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesion (IL) bolus abciximab
Number of subjects: 450
Study 25060015 — intervention group
Group type: COMPARATOR
Intervention: No abciximab
Number of subjects: 450
Study 25060015 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombus aspiration
Number of subjects: 450
Study 25060015 — intervention group
Group type: COMPARATOR
Intervention: No aspiration
Number of subjects: 450
Study 25060015 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter delay to reperfusion (<3 hours)
Number of subjects: 450
Study 25060015 — intervention group
Group type: COMPARATOR
Intervention: Longer delay to reperfusion (≥3 hours)
Number of subjects: 450
Study 22309242 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (30 mg/day)
Number of subjects: 28
Study 22309242 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate (160 mg/day)
Number of subjects: 28
Study 22309242 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 22309242 — intervention group
Group type: COMPARATOR
Intervention: Obese individuals (baseline comparison)
Number of subjects: 28
Study 20089730 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood n‐3 fatty acids (eicosapentaenoic acid)
Number of subjects: 61
Study 20089730 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood n‐6 fatty acids (arachidonic acid)
Number of subjects: 61
Study 20089730 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood trans fatty acids (total trans 18:1)
Number of subjects: 61
Study 20089730 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood monounsaturated fatty acids (oleic acid)
Number of subjects: 61
Study 20089730 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood saturated fatty acids
Number of subjects: 61
Study 17896781 — intervention group
Group type: EXPERIMENTAL
Intervention: Ductal carcinoma in situ component or poor nuclear grade tumors
Number of subjects: 638
Study 17896781 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumors arising in radial scars, tubular histologic type, moderate/marked tumor stroma
Number of subjects: 638
Study 17896781 — intervention group
Group type: EXPERIMENTAL
Intervention: Nuclear grade
Number of subjects: 638
Study 17896781 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphatic tumor extension
Number of subjects: 638
Study 17896781 — intervention group
Group type: EXPERIMENTAL
Intervention: Local breast irradiation and adjuvant therapy
Number of subjects: 638
Study 16116154 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive alkylator-based induction chemotherapy with or without autologous bone marrow transplantation (ABMT) with or without 13 cis-retinoic acid.
Number of subjects: 43
Study 12169044 — intervention group
Group type: EXPERIMENTAL
Intervention: Desloratadine 7.5mg daily with erythromycin 500mg every 8 hours for 10 days
Number of subjects: 24
Study 12169044 — intervention group
Group type: EXPERIMENTAL
Intervention: Desloratadine 7.5mg daily with erythromycin
Number of subjects: 24
Study 12169044 — intervention group
Group type: COMPARATOR
Intervention: Desloratadine 7.5mg daily with placebo
Number of subjects: 24
Study 10575337 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled glutathione (600 mg)
Number of subjects: 12
Study 10575337 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (20 mg)
Number of subjects: 12
Study 10575337 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 8543722 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychodynamic-interpersonal (PI) therapy
Number of subjects: 114
Study 8543722 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral (CB) therapy
Number of subjects: 114
Study 2085111 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrofurantoin
Number of subjects: 130
Study 2085111 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim
Number of subjects: 130
Study 29774647 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal movement counting (experimental group)
Number of subjects: 110
Study 29774647 — intervention group
Group type: COMPARATOR
Intervention: Continual routine monitoring (control group)
Number of subjects: 110
Study 28644314 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone starting position
Number of subjects: 181
Study 28644314 — intervention group
Group type: COMPARATOR
Intervention: Left-sided starting position
Number of subjects: 181
Study 27170445 — intervention group
Group type: EXPERIMENTAL
Intervention: BAT 1200 μg via DPI-D
Number of subjects: 48
Study 27170445 — intervention group
Group type: EXPERIMENTAL
Intervention: BAT 1200 μg via DPI-E without a lactose-filled second strip
Number of subjects: 48
Study 27170445 — intervention group
Group type: EXPERIMENTAL
Intervention: BAT 1200 μg via DPI-E with a lactose-filled second strip
Number of subjects: 48
Study 27170445 — intervention group
Group type: EXPERIMENTAL
Intervention: BAT/FF 1200/300 μg via DPI-E
Number of subjects: 48
Study 27170445 — intervention group
Group type: COMPARATOR
Intervention: FF 300 μg via DPI-E with a lactose-filled second strip
Number of subjects: 48
Study 27170445 — intervention group
Group type: EXPERIMENTAL
Intervention: BAT/FF 900/300 μg via DPI-E
Number of subjects: 48
Study 24526257 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 19
Study 24526257 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone (2.0 mg/kg/d)
Number of subjects: 19
Study 24526257 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 19
Study 22842891 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined health and employment promotion intervention (AmigA)
Number of subjects: 71
Study 22842891 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 71
Study 20207157 — intervention group
Group type: EXPERIMENTAL
Intervention: Solar radiation, broadband UVB, or use of sunbeds
Number of subjects: 0
Study 20207157 — intervention group
Group type: EXPERIMENTAL
Intervention: Broadband UVB phototherapy
Number of subjects: 0
Study 20207157 — intervention group
Group type: EXPERIMENTAL
Intervention: UV radiation
Number of subjects: 0
Study 20207157 — intervention group
Group type: COMPARATOR
Intervention: Sun or sunbeds
Number of subjects: 0
Study 18819024 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed patients
Number of subjects: 43
Study 18819024 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 43
Study 15556964 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural diamorphine 3 mg (high-volume, low-concentration solution)
Number of subjects: 62
Study 15556964 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural diamorphine 3 mg (low-volume, high-concentration solution)
Number of subjects: 62
Study 15556964 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall data for epidural diamorphine
Number of subjects: 62
Study 12824105 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-based learning case featuring spirituality as a prominent theme
Number of subjects: 192
Study 12824105 — intervention group
Group type: COMPARATOR
Intervention: Problem-based learning cases with no mention of spirituality
Number of subjects: 192
Study 10566877 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytosterol ester-enriched margarine (40 g containing 8.6 g vegetable oil phytosterol)
Number of subjects: 24
Study 10566877 — intervention group
Group type: COMPARATOR
Intervention: Control margarine (40 g)
Number of subjects: 24
Study 8712078 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitrectomy with autoserum instillation
Number of subjects: 34
Study 8712078 — intervention group
Group type: COMPARATOR
Intervention: Vitrectomy alone (without autoserum)
Number of subjects: 34
Study 8712078 — intervention group
Group type: EXPERIMENTAL
Intervention: Reoperation with autoserum
Number of subjects: 34
Study 1853989 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy
Number of subjects: 239
Study 1853989 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy
Number of subjects: 239
Study 1853989 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine with clinical management
Number of subjects: 239
Study 1853989 — intervention group
Group type: COMPARATOR
Intervention: Placebo with clinical management
Number of subjects: 239
Study 6881974 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole group (three-drug regimen: 5-FU, Adriamycin, and Levamisole)
Number of subjects: 81
Study 6881974 — intervention group
Group type: COMPARATOR
Intervention: Control group (two-drug regimen: 5-FU and Adriamycin)
Number of subjects: 81
Study 31439467 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Body Weight (TBW) dosing, 1.22 mL/kg
Number of subjects: 280
Study 31439467 — intervention group
Group type: COMPARATOR
Intervention: Lean Body Weight (LBW) dosing, 1.66 mL/kg for women and 1.52 mL/kg for men
Number of subjects: 280
Study 31439467 — intervention group
Group type: EXPERIMENTAL
Intervention: TBW dosing
Number of subjects: 280
Study 31439467 — intervention group
Group type: COMPARATOR
Intervention: LBW dosing
Number of subjects: 280
Study 31439467 — intervention group
Group type: EXPERIMENTAL
Intervention: TBW and LBW dosing
Number of subjects: 280
Study 30845095 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (10 or 30 mg)
Number of subjects: 63
Study 30845095 — intervention group
Group type: COMPARATOR
Intervention: Control (no Dexamethasone)
Number of subjects: 63
Study 30845095 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (10 mg)
Number of subjects: 63
Study 30845095 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (30 mg)
Number of subjects: 63
Study 29023215 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly Denosumab
Number of subjects: 0
Study 29023215 — intervention group
Group type: COMPARATOR
Intervention: Zoledronic Acid (ZA) every 3 months
Number of subjects: 0
Study 29023215 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly Zoledronic Acid (ZA)
Number of subjects: 0
Study 29023215 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 0
Study 26511380 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellar tendon strap during squatting at 30°
Number of subjects: 20
Study 26511380 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellar tendon strap during squatting at 60°
Number of subjects: 20
Study 26511380 — intervention group
Group type: COMPARATOR
Intervention: Unstrapped condition
Number of subjects: 20
Study 25581657 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg)
Number of subjects: 63
Study 25581657 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 63
Study 23020162 — intervention group
Group type: EXPERIMENTAL
Intervention: T-DM1
Number of subjects: 991
Study 23020162 — intervention group
Group type: COMPARATOR
Intervention: Lapatinib plus capecitabine
Number of subjects: 991
Study 19401207 — intervention group
Group type: EXPERIMENTAL
Intervention: High-pass fractal masker
Number of subjects: 0
Study 19401207 — intervention group
Group type: EXPERIMENTAL
Intervention: High-pass checkerboard masker
Number of subjects: 0
Study 19401207 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichoptic presentation
Number of subjects: 0
Study 17890830 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality improvement (QI) programs involving medication or psychotherapy
Number of subjects: 945
Study 17890830 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 945
Study 15126132 — intervention group
Group type: EXPERIMENTAL
Intervention: Bendroflumethiazide (2.5 mg)
Number of subjects: 0
Study 15126132 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide (40 mg)
Number of subjects: 0
Study 15126132 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11669431 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg hyperbaric bupivacaine with added fentanyl 20 microg (group BF)
Number of subjects: 42
Study 11669431 — intervention group
Group type: COMPARATOR
Intervention: 12.5 mg hyperbaric bupivacaine alone (group B)
Number of subjects: 42
Study 9481395 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesh herniorrhaphy
Number of subjects: 105
Study 9481395 — intervention group
Group type: COMPARATOR
Intervention: Shouldice herniorrhaphy
Number of subjects: 105
Study 7985742 — intervention group
Group type: EXPERIMENTAL
Intervention: CQ/CQ (sulfadoxine-pyrimethamine and/or chloroquine) for at least 45 days prior to delivery
Number of subjects: 159
Study 7985742 — intervention group
Group type: EXPERIMENTAL
Intervention: SP/CQ (treatment dose of sulfadoxine-pyrimethamine followed by weekly chloroquine prophylaxis)
Number of subjects: 159
Study 7985742 — intervention group
Group type: EXPERIMENTAL
Intervention: SP/SP (two-dose sulfadoxine-pyrimethamine regimen)
Number of subjects: 159
Study 7985742 — intervention group
Group type: EXPERIMENTAL
Intervention: CQ/CQ during peak transmission season (April to July)
Number of subjects: 159
Study 7985742 — intervention group
Group type: EXPERIMENTAL
Intervention: SP/CQ during peak transmission season (April to July)
Number of subjects: 159
Study 7985742 — intervention group
Group type: EXPERIMENTAL
Intervention: SP/SP during peak transmission season (April to July)
Number of subjects: 159
Study 2510618 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 281
Study 2510618 — intervention group
Group type: COMPARATOR
Intervention: Antacid
Number of subjects: 281
Study 31732771 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Voiding Trials (AVT)
Number of subjects: 274
Study 31732771 — intervention group
Group type: COMPARATOR
Intervention: Passive Voiding Trials (PVT)
Number of subjects: 274